Alem A. Belachew
- Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Chronic Lymphocytic Leukemia Research 1
- Hematology top 1%
- Acute Myeloid Leukemia Research 5
- Rheumatology top 5%
-
- Kruppel-like factors research 4
- Ubiquitin and proteasome pathways 1
-
- Cancer survivorship and care 1
- Global Cancer Incidence and Screening 1
-
- Economic and Financial Impacts of Cancer 1
- Co-authors
- Curtis A. HansonAyalew TefferiTerra L. LashoChristy M. FinkeAnimesh PardananiEmnet A WassieRhett P. KetterlingAlessandro M. Vannucchi
- Cited by
- GeneticsHematologyRheumatology
- Partner nations
- United StatesItalyGermany
In The Last Decade
Alem A. Belachew
10 papers receiving 999 citations
Hit Papers
Peers
Comparison fields: 5 of 33
- Genetics 950
- Hematology 783
- Rheumatology 326
- Molecular Biology 581
- Nephrology 24
Countries citing papers authored by Alem A. Belachew
This map shows the geographic impact of Alem A. Belachew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alem A. Belachew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alem A. Belachew more than expected).
Fields of papers citing papers by Alem A. Belachew
This network shows the impact of papers produced by Alem A. Belachew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alem A. Belachew. The network helps show where Alem A. Belachew may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alem A. Belachew, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 0 | |
| 2 | 2020 | 1 | |
| 3 | 2020 | 14 | |
| 4 | 2018 | 8 | |
| 5 | 2015 | 3 | |
| 6 | 2015 | 62 | |
| 7 | 2014 | 199 | |
| 8 | 2014 | 149 | |
| 9 | 2014 | 81 | |
| 10 | 2014 | 2 | |
| 11 | Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosisbreakdown → | 2014 | 493 |
About Alem A. Belachew
Alem A. Belachew is a scholar working on Genetics, Hematology, Oncology, Molecular Biology and Cancer Research, having authored 11 papers that have together received 1.0k indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (5 papers), Kruppel-like factors research (4 papers), Chronic Lymphocytic Leukemia Research (1 paper), Cancer survivorship and care (1 paper), Global Cancer Incidence and Screening (1 paper), Ubiquitin and proteasome pathways (1 paper) and Economic and Financial Impacts of Cancer (1 paper). The work is most often cited by research in Genetics (950 citations), Hematology (783 citations), Rheumatology (326 citations), Molecular Biology (581 citations) and Nephrology (24 citations). Alem A. Belachew has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Curtis A. Hanson, Ayalew Tefferi, Terra L. Lasho, Christy M. Finke, Animesh Pardanani, Emnet A Wassie, Rhett P. Ketterling, Alessandro M. Vannucchi, Paola Guglielmelli and Naseema Gangat. Their work appears in journals such as American Journal of Hematology, Leukemia, Blood, Neoplasia and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.